Vertex to Present at the Morgan Stanley Virtual 19th Annual Global Healthcare Conference on September 15th

Rhea-AI Summary

Vertex Pharmaceuticals (NASDAQ: VRTX) will present at the Morgan Stanley 19th Annual Global Healthcare Conference on September 15, 2021, at 11:00 a.m. ET. The presentation will be available live on Vertex's website in the Investors section. Vertex is a biotechnology company known for developing transformative medicines for serious diseases, including cystic fibrosis. The company has a robust pipeline focused on various serious conditions and is recognized as one of the industry's top places to work.

BOSTON--(BUSINESS WIRE)-- Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that management will present at the Morgan Stanley Virtual 19^th Annual Global Healthcare Conference on Wednesday, September 15^th, 2021 at 11:00 a.m. ET.

The audio portion of management's remarks will be available live through Vertex's website, www.vrtx.com in the "Investors" section under the "News and Events" page. A replay of the conference webcast will be archived on the company's website.

About Vertex

Vertex is a global biotechnology company that invests in scientific innovation to create transformative medicines for people with serious diseases. The company has multiple approved medicines that treat the underlying cause of cystic fibrosis (CF) — a rare, life-threatening genetic disease — and has several ongoing clinical and research programs in CF. Beyond CF, Vertex has a robust pipeline of investigational small molecule medicines in other serious diseases where it has deep insight into causal human biology, including pain, alpha-1 antitrypsin deficiency and APOL1-mediated kidney diseases. In addition, Vertex has a rapidly expanding pipeline of genetic and cell therapies for diseases such as sickle cell disease, beta thalassemia, Duchenne muscular dystrophy and type 1 diabetes mellitus.

Founded in 1989 in Cambridge, Mass., Vertex's global headquarters is now located in Boston's Innovation District and its international headquarters is in London. Additionally, the company has research and development sites and commercial offices in North America, Europe, Australia and Latin America. Vertex is consistently recognized as one of the industry's top places to work, including 11 consecutive years on Science magazine's Top Employers list and a best place to work for LGBTQ equality by the Human Rights Campaign. For company updates and to learn more about Vertex's history of innovation, visit www.vrtx.com or follow us on Facebook, Twitter, LinkedIn, YouTube and Instagram.

(VRTX-WEB)

View source version on businesswire.com: https://www.businesswire.com/news/home/20210913005186/en/

Vertex Pharmaceuticals Incorporated Investors:

Michael Partridge, 617-341-6108

Brenda Eustace, 617-341-6187

Manisha Pai, 617-429-6891

Source: Vertex Pharmaceuticals Incorporated

FAQ

When is Vertex Pharmaceuticals presenting at the Morgan Stanley Conference?

Vertex Pharmaceuticals will present on September 15, 2021, at 11:00 a.m. ET.

How can I listen to the Vertex Pharmaceuticals presentation?

The audio portion can be accessed live through the Vertex website in the Investors section.

What is Vertex Pharmaceuticals known for?

Vertex Pharmaceuticals specializes in developing transformative medicines for serious diseases, particularly cystic fibrosis.

What is the stock symbol for Vertex Pharmaceuticals?

The stock symbol for Vertex Pharmaceuticals is VRTX.

What type of diseases does Vertex Pharmaceuticals focus on?

Vertex focuses on serious diseases, including cystic fibrosis and has ongoing development in pain management, kidney diseases, and genetic disorders.